17. Outcomes of nutritional intervention in children with chylothorax after cardiac surgery in Vietnam National Children’s Hospital
Main Article Content
Abstract
Nutritional treatment has demonstrated beneficial effects in managing chylothorax in children after heart surgery. A cross-sectional study with 26 children treated for chylothorax after cardiac surgery was conducted at the National Children’s Hospital from 01/01/2022 to 30/08/2023. The cases comprised of 61.5% male and 38.5% female, with ages ranging from 13 days to 45 months; the majority were within 1 - 12 months old (65.4%). The most common causes of chylothorax was Tetra of Fallot and Coarctation of the aorta, accounting for 19.2%. There were 21 children underwent MCT-rich diet treatment (MCT-diet), while 5 children received total parenteral nutrition method (TPN). Following treatment, 25 showed successful recovery, with the remaining child needing invasive intervention. Weight loss rate of 42.3% was observed in the study. Treatment-related complications included sepsis (34.6%), hypoalbuminemia (53.8%), elevated liver enzymes (11.5%), and renal abnormalities (61.5%). Median drainage time, mechanical ventilation time, and length of hospital stay were 6 days, 4 days, and 29 days, respectively. Nutritional treatment can be an effective treatment option for chylothorax in children.
Article Details
Keywords
Chylothorax after cardiac surgery, outcome, nutrition treatment, MCT-diet
References
2. Allen EM, van Heeckeren DW, Spector ML, Blumer JL. Management of nutritional and infectious complications of postoperative chylothorax in children. J Pediatr Surg. 1991; 26(10): 1169-1174. doi:10.1016/0022-3468(91)90325-n.
3. Ruangnapa K, Anuntaseree W, Saelim K, Prasertsan P, Puwanant M, Dissanevate S. Treatment and outcomes of chylothorax in children: 20-year experience of a single institute. J Thorac Dis. 2022; 14(10): 3719-3726. doi:10.21037/jtd-22-474.
4. Chan S yan, Lau W, Wong WHS, et al. Chylothorax in Children After Congenital Heart Surgery. The Annals of Thoracic Surgery. 2006; 82(5): 1650-1656. doi:10.1016/j.athoracsur.2006.05.116.
5. Biewer ES, Zürn C, Arnold R, et al. Chylothorax after surgery on congenital heart disease in newborns and infants -risk factors and efficacy of MCT-diet. J Cardiothorac Surg. 2010; 5:127. doi:10.1186/1749-8090-5-127.
6. Chan EH, Russell JL, Williams WG, et al. Postoperative chylothorax after cardiothoracic surgery in children. Ann Thorac Surg. 2005; 80(5): 1864-1870. doi:10.1016/j.athoracsur.2005.04.048.
7. Church JT, Antunez AG, Dean A, et al. Evidence-based management of chylothorax in infants. Journal of Pediatric Surgery. 2017; 52(6): 907-912. doi:10.1016/j.jpedsurg.2017.03.010.
8. Cormack BE, Wilson NJ, Finucane K, et al. Use of Monogen for pediatric postoperative chylothorax. Ann Thorac Surg. 2004 Jan; 77(1): 301-5. doi: 10.1016/s0003-4975(03)01189-5. PMID: 14726083.
9. Puntis JW, Roberts KD, Handy D. How should chylothorax be managed? Arch Dis Child. 1987; 62(6):593-596. doi:10.1136/adc.62.6.593.
10. Nguyen DM, Shum-Tim D, Dobell AR, et al. The management of chylothorax/chylopericardium following pediatric cardiac surgery: a 10-year experience. J Card Surg. 1995; 10(4 Pt 1): 302-308. doi:10.1111/j.1540-8191.1995.tb00616.x.
11. Zheng J, Chen YY, Zhang CY, et al. Incidence and Nutritional Management of Chylothorax after Surgery for Congenital Heart Diseases in Children. Heart Surg Forum. 2020; 23(6):E902-E906. doi:10.1532/hsf.3219.
12. Bui A, Long CJ, Breitzka RL, Wolovits JS. Evaluating the Use of Octreotide for Acquired Chylothorax in Pediatric Critically Ill Patients Following Cardiac Surgery. J Pediatr Pharmacol Ther. 2019 Sep-Oct; 24(5): 406-415. doi: 10.5863/1551-6776-24.5.406. PMID: 31598104; PMCID: PMC6782119.